Fig. 2.
Purification of in vitro–generated effector cells results in removal of residual monocytic accessory cells.
(A) Extent of monocyte contamination in effector CD4 T-cell preparations before monocyte depletion with anti-CD14 beads and after depletion. (B) CD4 expression profile of purified effector CD4 T cells.